Breast cancer is the most commonly diagnosed cancer in women and the second leading cause of cancer death in women in the US, after lung cancer.1 Approximately 30% of breast cancer cases are preventable, being attributed to modifiable risk factors, such as excess body weight, low physical activity, and high alcohol intake.2 However, for 7-10% of breast cancer cases, there is a germline genetic component that underlies susceptibility.3–6 It has been shown that the cumulative breast cancer risk to age 80 years is 72% and 69% for BRCA1 and BRCA2 mutation carriers, respectively.7 Additionally, there are patients with pathogenic variants in other genes that increase one’s susceptibility for developing breast cancer, and there are patients with a strong family history without a known pathogenic variant. Several breast cancer risk prediction models help guide management of these patients.8For patients with a hereditary susceptibility in particular, there are several active ways to reduce the risk of breast cancer, including risk-reducing medication, salpingo-oophorectomy, and risk-reducing mastectomy (RRM).9 For RRM, patients may be offered a total, skin-sparing, or nipple-sparing mastectomy, and reconstruction may be offered with consideration of timing and type of reconstruction. Bilateral RRM has been shown to decrease the risk of breast cancer by 90-95%, regardless of mastectomy type (ex: nipple-sparing vs total mastectomy). 10–13 A variety of factors may influence a patient’s decision to undergo RRM, with or without reconstruction, and one such factor is family structure, with patients undergoing RRM being more often married with a history of pregnancy.14,15 Despite the potential benefits of RRM, negative outcomes may also be associated with surgery. RRM can cause women to experience anxiety and concerns about their body image, along with difficulties with feelings of femininity and/or sexual relationships.16,17Therefore, the benefits of RRM must be balanced with the potential risks of surgery when deciding to undergo surgery. To this end, there is a need for more consolidated information on patient-reported outcomes (PROs) following RRM (with or without reconstruction), especially in the months following surgery. This specific time frame is important to distinguish from long-term outcomes because the effects of surgery within the first year may be quite different from those observed several years later. The aim of this systematic review is to summarize short-term patient-reported outcomes following bilateral RRM in patients with an increased risk of developing breast cancer.
METHODS
The reporting of this systematic review was guided by the standards of the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) Statement (Supplementary Figure 2).18,19 A medical librarian with expertise in systematic searching composed a sensitive search utilizing a mix of keywords and subject headings, provided by the coauthors with clinical expertise, to represent the concepts of prophylactic mastectomy, breast cancer, patient-reported outcomes, and risk. The databases MEDLINE via PubMed, Embase via Elsevier, and Scopus via Elsevier, were searched from inception to October 12, 2023. All search results were compiled into EndNote and imported into Covidence for deduplication and screening. All reproducible search strategies are available in the supplementary materials (Supplemental Figure 1).
We used a PICO search strategy to inform the inclusion criteria for the systematic review. The patient population is patients who are at increased risk of developing breast cancer (from a known pathogenic variant or family history) and who do not have a prior or concurrent history of breast cancer. Our intervention is bilateral risk-reducing mastectomy (RRM), aimed at reducing the risk of breast cancer. Our outcome is short-term (< 1 year after surgery) quality of life patient-reported outcomes (PROs) regarding overall satisfaction with the surgery result, satisfaction with the decision to have surgery, regret, psychosocial well-being, body image, aesthetic satisfaction, sexual well-being, partner relationship satisfaction, somatosensory function, and chest health. We excluded studies that were case reports, review articles, and those that included women with a personal history of breast cancer at the time of RRM in the analysis.
All the included studies were transferred to Covidence, and duplicates were removed. The titles and abstracts that were considered relevant were independently screened by three individuals (ML, KN, VY). Each full-text manuscript was reviewed independently by at least two reviewers (ML, KN, VY), and discrepancies were resolved by discussion between at least 2 reviewers.
Data extraction and quality assessment were completed by ML, KN, and VY using a Google Form. All conflicts were resolved by KN. Quality assessment was completed using the validated Methodological Index for Non-Randomized Studies (MINORS)20. The MINORS score uses a 3-point scale to rate the quality of each specification, including 2 (reported and adequate), 1 (reported but inadequate), and 0 (not reported). Non-comparative studies had a maximum score of 16 (8 questions) and comparative studies had a maximum score of 24 (12 questions). Data extraction was collected on study design, patient characteristics, surgery type, and PROs. A result was considered positive if it had an improved score compared to the preoperative period or if greater than 70% of patients rated that item positively. A p-value less than or equal to 0.05 was considered statistically significant.
RESULTS
Our initial search yielded 3277 studies for screening. After removing 1419 duplicates, 1858 remained for the title and abstract screening. Of those, 1771 studies were deemed unrelated to the study aim, and 87 full-text manuscripts were assessed for inclusion. Following full-text screening of the 87 manuscripts, 76 studies did not meet inclusion criteria, and 11 studies remained for final inclusion (Figure 1).21–31 Reasons for exclusion were as follows: 32/76 had the wrong follow-up time, 20/76 were meeting abstracts, 8/76 did not specifically examine patients who underwent bilateral RRM with no history of breast cancer, 8/76 had the wrong study design (ex: qualitative study, review, etc.), 6/76 were not in English, and 2/76 did not measure PROs.
Of the 11 studies included, 10 were prospective cohorts, 21–26,28–31 and one was a case series.27 There were 9 studies that exclusively included patients who underwent RRM with reconstruction21–25,27–30, while 2 studies included patients who did and did not receive breast reconstruction.26,31 A total of 599 patients were included in this systematic review, 5 of whom did not receive breast reconstruction after RRM. The studies took place in a range of countries, including 1 from Denmark25, 2 from Italy22,28, 3 from the Netherlands23,24,26, 1 from Sweden21, 1 from Turkey30, and 3 from the United States.27,29,31 Study population sizes ranged from 14 – 204 patients. For quality assurance, MINORS scores for included studies ranged from 11 to 21, indicating some lower quality studies and some higher quality studies. Scores were considered to have a low risk for bias if they had a MINORS score greater than 12 points for noncomparative studies and greater than 20 points for comparative studies32. Instruments used included the BREAST-Q survey in 5/11 studies22,25,27–29, and ad hoc in 6/11 studies (Table 1). 21,23,24,26,30,31
Measurement of general satisfaction with the mastectomy outcome was included in 9/11 of the included studies. 21–23,25,27–31 All but one31 of these studies exclusively included patients who received post-mastectomy reconstruction.
The BREAST-Q questionnaire was used in 5 of these 9 studies to compare preoperative breast satisfaction to postoperative breast satisfaction.22,25,27–29 All 5 of these studies show a higher satisfaction score in the postoperative setting, although one of these was not a statistically significant difference from the preoperative score. 27
The remaining 4 studies used ad hoc instruments to measure the percentage of patients who were satisfied with their surgery.21,23,30,31 Satisfaction ranged from 64% to 100%, indicating an overall positive satisfaction with surgery.
Brandberg et al. additionally found a statistically significant correlation between satisfaction with the surgery result and mutation carrier status, with patients who are not known carriers reporting more positive outcomes (p = 0.037).21 Contant et al. found a negative correlation between prosthesis-related complaints and general satisfaction with the outcome (p = 0.01). 21
Three studies specifically looked at the decision to undergo bilateral RRM and post-operative regret.23,30,31 All studies reported high levels of satisfaction with the decision to undergo RRM, with satisfaction percentages ranging from 88%-100%. The one study that asked about regret reported that 10% of participants would dissuade others from having the surgery they underwent.23
Seven studies reported on psychosocial well-being22,24,25,27–29,31, 5 of which used the BREAST-Q questionnaire.22,25,27–29 All studies showed generally positive postoperative psychosocial well-being measures. All 6 of the studies that compared preoperative scores to postoperative scores showed improvement in postoperative psychosocial well-being levels.22,24,25,27–29 The 5 studies that used the BREAST-Q questionnaires showed a mean increase of psychosocial well-being in the post-operative setting ranging from 6-12.9, with 3 out of 5 of these being statistically significant differences. Gopie et al completed a similar measurement using the Mental Component Summary (MCS; higher scores indicate better mental health) survey which found an increase in general mental health score from 48 preoperatively to 51 post-operatively (p = 0.02).24 Stefanek et al. reported that 93% of their participants were satisfied with their time to recover emotionally.31
Five studies reported on body image and aesthetic satisfaction.21,23,24,26,30 This included reports on the shape, softness, symmetry, and general appearance of the breasts. There were 4 studies that reported on the overall appearance and symmetry of the breasts.21,23,26,30 Percent satisfaction with the appearance of the breasts ranged from 58-60%, while perceived symmetry ranged from 50-90.4%. There were mixed findings on the softness of the breasts, with one study showing 51% satisfaction with softness21, another study reporting that 59% of participants felt that their breasts felt artificial23, and another study showing that 90.4% of participants considered their breasts to be soft to the touch.30 For overall body image, Gopie et al showed worse body image outcomes postoperatively compared to preoperatively (p<0.001).24 Additionally, body image was found to be negatively correlated with BMI (p = 0.004) and positively correlated with preoperative general health (p = 0.005). Notably, Lodder et al showed that 50% of participants were dissatisfied with their bodies while undressed.26
Eight studies included metrics on sexual well-being and partner relationship satisfaction.22–29 Of these studies, 6 directly compared preoperative scores to postoperative scores22,24,25,27,29, with 5 of these using the BREAST-Q questionnaire.22,25,27,29 The studies that used BREAST-Q reported mixed outcomes for sexual well-being scores in the postoperative period, with the change ranging from −1.1 to + 10.2, with only 2 of those differences being statistically significant.22,28 Gopie et al. used the Dutch Relationship Questionnaire to show a statistically insignificant decrease in sexual relationships postoperatively and no change in partner relationship satisfaction.24 Contant et al showed that 77% of participants reported that their partners did not need to feel inhibited in their sexual relations23, while Lodder et al found that 50% of participants reported not feeling sexually attractive.26 Lodder also surveyed the patients’ partners and found that 0% of partners no longer found the patient sexually attractive, but 33% reported dissatisfaction with the appearance of the partners’ breasts.26
Six studies reported on somatosensory function and chest health.21,24,25,27–29 All of these studies exclusively included patients who underwent post-mastectomy reconstruction. There were 4 studies that used the BREAST-Q questionnaire to report on physical well-being25,27–29, which showed mixed results with postoperative values changing by − 8.6 to + 4. One study used SF-36 to measure general physical health, which decreased from 55 preoperatively to 48 postoperatively.24 Brandberg et al. showed that 73% of participants reported little to no sensitivity/sensation in the breasts postoperatively.21 McCarthy et al. also used the SF-MPQ to show increased levels of pain 1 year after the surgery.29
DISCUSSION
In the era of increased access to genetic testing, more germline pathogenic genetic mutations that increase one’s susceptibility to developing breast cancer are being identified. Therefore, it is important for patients to have information not only on breast cancer risk reduction, but on patient-reported outcomes as well, so they can make an informed decision, if RRM with or without reconstruction is the best decision for them. Our study highlights several key findings. Overall, we showed that the majority of patients are satisfied with the outcome of their RRM. They report high levels of satisfaction with their decision to undergo RRM, and very few patients report regret about their decision to have surgery. Additionally, patients reported improved psychosocial well-being after surgery. For aesthetic outcomes and body image, patients reported both positive and negative outcomes, even given that most of the patients included in these studies opted for reconstruction. Finally, for sexual well-being and partner relationships, most outcomes were positive, with some negative patient reports. Therefore, our findings demonstrate that patients who elected for RRM with or without reconstruction tend to be satisfied with their decisions, with a distinct improvement in psychosocial well-being, but awareness of some considerations is likely also important.
To begin, it is critical to address some of the drivers of RRM decision-making in patients at high risk of developing breast cancer. One study by Record et al. used a retrospective chart review of 306 patients to show that family structure, comorbidities, and other breast diagnoses were associated with RRM receipt in patients with BRCA1/2 diagnoses.33 This is supported by a study from Henry et al. which used a survey of 282 patients to show that factors such as parity, income, ovarian cancer history, and the number of first-degree relatives with breast cancer influence the decision to pursue RRM.34 Therefore, we can likely infer that a patient’s state in life and anecdotal proximity to breast cancer may influence their decision to undergo RRM, with many choosing breast reconstruction as well. Another relevant benefit of RRM to consider for some patients is that it can be more cost-effective than surveillance, as breast imaging is not routinely recommended after bilateral RRM.35
For patients who ultimately decide to have RRM, our systematic review shows that patients seem to report high levels of satisfaction with the short-term outcomes of surgery. We had 9 out of the 11 included studies report on this result, with most patients undergoing reconstruction, and all of them reported overall positive levels of satisfaction with the surgery results.21–23,25,27–31 This is a reassuring finding, indicating that those who elect to have RRM are generally happy with their outcomes. It is possible that this is at least in part due to a self-fulfilling bias, given that these patients have chosen surgery as opposed to increased surveillance. One qualitative study conducted by Morgan et al. found high levels of satisfaction with risk reduction strategies in both patients who opted for surveillance only and those who chose RRM.36 This indicates that either most patients ultimately choose the risk-reduction strategy that is best for them, or that most patients would be satisfied regardless of their risk management strategy.
Interestingly, there are some instances where the patients’ reports on body image and aesthetic satisfaction contradict general satisfaction with the outcome of the surgery. Notably, there were 5 studies that measured aesthetic satisfaction or body image, of which 3 reported negative outcomes and 2 reported positive outcomes.21,23,24,26,30 Only one of those studies included patients who did not choose post-mastectomy reconstruction. The lack of concordance between overall satisfaction with surgery outcomes and satisfaction with aesthetic results indicates that aesthetic outcomes might not be the main indicator of a successful surgery result for the patient. In this case of healthy patients opting for risk-reducing surgery (many with post-mastectomy reconstruction), if aesthetics are not a major factor for overall outcome, then perceived risk reduction may be contributing to the positive perception of the surgical outcomes. This is supported by a study conducted by Mansfield et al. showing that for patients with a BRCA1/2 mutation, their risk reduction strategy decision is primarily driven by achieving the highest degree of risk reduction.37
This point is further supported by our systematic review’s findings that patients reported improved psychosocial well-being postoperatively. All 7 of the studies that reported on psychosocial well-being showed positive outcomes, with 6 of those showing a direct improvement from the preoperative period to the postoperative period.22,24,25,27–29,31 This indicates that mental peace of mind may influence satisfaction following RRM. Our findings are supported by the literature, with Segerer et al. showing that fear and anxiety impact risk-reduction decision-making in patients with BRCA1/2 mutations, and Metcalfe et al. showing lower levels of distress in patients with BRCA1/2 mutations who had risk-reducing surgery.38,39 This furthers the point that the decision to pursue RRM is a deeply personal choice and that adequate counseling is necessary to ensure that the patient’s mental and physical needs are being considered.
Additionally, while it is well understood that RRM dramatically decreases the risk of breast cancer, this topic is complicated by the potential for both short- and long-term postoperative negative outcomes in otherwise healthy patients.10 One historical study by Barton et al found that almost two-thirds of their 269-person cohort of patients who received bilateral RRM experienced some type of unwanted outcome in the mean follow-up of 7.4 years. While this number has likely decreased since 2005, there is likely still not a significant number of patients who experience negative outcomes. This is further supported by our review’s finding of pain and decreased sensation in some patients. Of the 6 studies in this systematic review that reported on chest health and somatosensory well-being, only one had an overall positive result.21,24,25,27–29 The other studies found outcomes including little to no breast sensation/sensitivity, post-operative pain lasting months, and worsened chest health when compared to the preoperative baseline. While many patients may view these effects as minor inconveniences when compared to their risk of breast cancer, it is important that patients are counseled about this potential outcome before they decide to undergo RRM.
However, there have been attempts to decrease some of these negative outcomes with new surgical techniques. One such technique is prepectoral implant-based reconstruction, which aims to reduce surgical morbidity caused by chest wall dissection.40 One study in our systematic review that only included patients who underwent prepectoral implant-based reconstruction was the only included study that showed improved physical well-being after surgery. Nonetheless, more data on this topic is needed to confirm if this was due to the technique alone.28 Another way to mitigate post-mastectomy sensory issues is through a nerve preservation or re-sensation surgery with allografting.41,42 These techniques have the potential to improve outcomes, although more long-term data is needed to prove its lasting efficacy.
Other PROs to consider include sexual well-being and partner satisfaction after surgery.22–29 We had 8 studies report on this finding (7 of which exclusively included patients who underwent reconstruction) and 3 of those 8 studies included negative results. While several studies reported improved sexual well-being in the postoperative period and no need for their partner to feel inhibited in their sexual relations, others showed worse sexual well-being, participants not feeling sexually attractive, and a portion of partner dissatisfaction. Again, it seems that most patients value breast cancer risk reduction more, but this is still an important clinical outcome for patients to be aware of. Sexual well-being is an especially relevant factor given that many women report embarrassment discussing their sexual well-being and health with their healthcare providers, so it is especially important for providers who counsel on risk-reduction strategies to bring up these topics.
Overall, our systematic review found high levels of satisfaction with the decision to have an RRM and low levels of regret, with participants reporting that they would make the same decision again and very few participants stating that they would dissuade other patients from having the same procedure.23,30,31 These uniformly positive findings indicate that the types of patients who do choose to undergo RRM tend to be satisfied with this decision regardless of outcomes, likely because they value their decreased breast cancer risk.
There are several areas of potential future work. For example, it is known that there are systemic barriers to risk-reducing strategies for patients with hereditary cancer syndromes, so future work may want to examine how these barriers may affect underserved groups and their perceptions of the PROs.43 There are also a few other systematic reviews that look at PROs following RRM; however, compared to some of the older reviews, we provide more updated data on these PROs and additional PROS like chest health.44–46 Future work could focus on similar outcomes and include more qualitative studies to further determine the direct patient reasoning behind their decisions and evaluations of their outcomes.
There exist several limitations to this study. First, this study serves as a descriptive review utilizing unvalidated ad hoc instruments studying PRO measures. Therefore, it may be challenging to confirm the clinical significance of these findings. Additionally, the study quality was evaluated in a variable manner through the MINORS criteria. Therefore, further appraisal of review sources with the incorporation of higher-level evidence would strengthen the results presented in our study. Additionally, many investigations included in this review had limited cohort sizes of fewer than 50 individuals. It would be helpful to have more data to tease out the granularity of which risk-reduction strategies would be the most beneficial to each patient based on their individual level of risk. This study reviewed survey-based PRO measures for individuals undergoing prophylactic mastectomies. Though survey-based patient-reported measures are becoming widely used and more standardized, incorporating analyses of qualitative patient descriptions can provide more detailed insight into PROs. Finally, all surveys not written in English were excluded from this study, potentially limiting the generalizability of the study results for non-English speaking populations.
To conclude, our study provides valuable information about the short-term outcomes that patients report after RRM. Patients who opt to undergo RRM are generally satisfied with their decision and outcome, which may be most related to postoperative peace of mind over other PROs. However, there are some possible unwanted outcomes, such as worse body image and sexual well-being, that should be considered. When counseling a patient about RRM, a multidisciplinary approach including a breast surgeon, plastic surgeon, and access to a clinical psychologist if needed should be used in clinical settings to help each individual patient make an informed decision about whether surgery is the best option for them.
JP
Dr. Jennifer Plichta
Surgery · Breast Surgical OncologyDuke Medical Centerjenniferp